Clinical trials
Recruiting Phase 1 Mesothelioma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| A&G Pharmaceutical Inc. | 1 |
| BridGene Biosciences Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| IDEAYA Biosciences | 1 |
| KaliVir Immunotherapeutics | 1 |
| National Cancer Institute (NCI) | 1 |
| SHY Therapeutics | 1 |
| Second Affiliated Hospital of Guangzhou Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mesothelioma | 8 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Pancreatic Neoplasms | 4 |
| Lung Neoplasms | 3 |
| Colonic Neoplasms | 2 |
| Stomach Neoplasms | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Carcinoma, Renal Cell | 1 |
| Carcinoma, Squamous Cell | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.